Precigen (PGEN) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Precigen (PGEN) over the last 13 years, with Q3 2025 value amounting to $1.0 million.

  • Precigen's Cost of Revenue rose 257.68% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 134.65%. This contributed to the annual value of $4.3 million for FY2024, which is 3026.64% down from last year.
  • Per Precigen's latest filing, its Cost of Revenue stood at $1.0 million for Q3 2025, which was up 257.68% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Precigen's Cost of Revenue ranged from a high of $7.4 million in Q1 2021 and a low of $914000.0 during Q2 2021
  • Its 5-year average for Cost of Revenue is $1.7 million, with a median of $1.3 million in 2022.
  • Over the last 5 years, Precigen's Cost of Revenue had its largest YoY gain of 11787.39% in 2021, and its largest YoY loss of 8877.29% in 2021.
  • Over the past 5 years, Precigen's Cost of Revenue (Quarter) stood at $2.9 million in 2021, then plummeted by 56.46% to $1.3 million in 2022, then increased by 8.04% to $1.4 million in 2023, then dropped by 13.92% to $1.2 million in 2024, then fell by 11.46% to $1.0 million in 2025.
  • Its Cost of Revenue was $1.0 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.